KENYON LAWRENCE A

Average Profitability
17.42%
Insider Buys Quantity
3
Insider Buys Sum
$69,126.00
Insider Sells Quantity
3
Insider Sells Sum
$72,530.10

Insider Activity of KENYON LAWRENCE A

According to the SEC Form 4 filings, KENYON LAWRENCE A, being in a position of

  1. Chief Financial Officer at Outlook Therapeutics, Inc.,
    оver the last 12 months, has bought 5000 shares for $28,446, and sold 0 shares,
    over all time since 2017-12-22, has bought 40000 shares for $69,126, and sold 65130 shares for $72,530.

The largest purchase of all time was on 2024-09-26 and amounted to 5000 shares of Outlook Therapeutics, Inc. for $28,446.

The largest sale of all time was on 2017-12-22 and amounted to 52330 shares of Outlook Therapeutics, Inc. for $59,133.

Biography of KENYON LAWRENCE A

No biography is available at this moment.

2024-09-26PurchaseOutlook Therapeutics, Inc.
OTLK
Chief Financial Officer
5,000
0.0216%
$5.69$28,4460%
2021-04-20PurchaseOutlook Therapeutics, Inc.
OTLK
CEO, Pres, CFO, Treas & Secy
10,000
0.0061%
$1.83$18,300+17.42%
2019-09-18SaleOutlook Therapeutics, Inc.
OTLK
CEO, Pres, CFO, Treas & Secy
2,700
0.0095%
$1.70$4,590-35.5%
2019-02-07PurchaseOutlook Therapeutics, Inc.
OTLK
CEO, Pres, CFO, Treas & Secy
25,000
0.027%
$0.90$22,380-77.9%
2018-09-18SaleOutlook Therapeutics, Inc.
OTLK
CEO, Pres, CFO, Treas & Secy
10,100
0.0254%
$0.87$8,807-34.09%
2017-12-22SaleOutlook Therapeutics, Inc.
OTLK
CFO and Secretary
52,330
0.2004%
$1.13$59,133-22.88%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.